title: [Demographic characteristics, malaria chemoprophylaxis and vaccination in 6,783 international travelers attended in a specialized unit].
abstract: OBJECTIVE
  The objective of this paper was to determine the demographic characteristics and the evolution of international travelers treated at the Unit of Infectious and Tropical Medicine in order to improve precautions prior to travel and, thus reduce the occurrence of these diseases.
  
  
  METHODS
  A retrospective study of all international travelers served in UEIMT (Las Palmas de Gran Canaria) during the period 1998-2013 was performed. The following variables were collected using a standardized protocol were analyzed: age, gender, date of consultation, type of traveler, countries of destination and preventive measures undertaken (malaria chemoprophylaxis and vaccines).
  
  
  RESULTS
  A total of 6,783 international travelers of which 52% were women were analyzed. The average age was 36 years (SD 13). The most frequent destination continent was Africa (39%) followed by Asia (36%) and Latin America (23%). The most common country of destination was India 13% (882), followed by Senegal 7.5% (509) and Thailand 6.3% (429). The most frequently recommended vaccines were typhoid fever (82.9%) and hepatitis A (66.9%). As for malaria prophylaxis, the indicated drugs were atovaquone-proguanil (56.5%), mefloquine (36.7%), in regard to travelers returning to visit relatives and friends with a 26.81% were children (0-9 years)..
  
  
  CONCLUSIONS
  The overall profile of the traveler is a young man who chooses holiday destination Africa followed by Asia and Latin America. Over 50% of travelers received vaccination against typhoid and hepatitis A. The most commonly used malaria chemoprophylaxis was atovaquone / proguanil followed by mefloquine.
authors.forename: N
authors.initials: N
authors.lastname: Jaén-Sánchez
authors.forename: L
authors.initials: L
authors.lastname: Suárez-Hormiga
authors.forename: C
authors.initials: C
authors.lastname: Carranza-Rodríguez
authors.forename: M
authors.initials: M
authors.lastname: Hernández-Cabrera
authors.forename: E
authors.initials: E
authors.lastname: Pisos-Álamo
authors.forename: L
authors.initials: L
authors.lastname: García-Reina
authors.affiliation: José Luis Pérez Arellano, Unidad de Enfermedades Infecciosas y Medicina Tropical. Hospital Universitario Insular de Gran Canaria. Avda Marítima del Sur 35080. Las Palmas de Gran Canaria, Spain. jlperez@dcmq.ulpgc.es.
authors.forename: J L
authors.initials: JL
authors.lastname: Pérez-Arellano
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000453:epidemiology* / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012621:Seasons; D012737:Sex Factors; D012959:Socioeconomic Factors; D013030:Spain / Q000453:epidemiology; D014195:Travel; D014611:Vaccination / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D000962:Antimalarials; D017780:Malaria Vaccines